DOCSLIB.ORG

CMK-VP PHYS PHAR 1008:Layout 4.Qxd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CMK-VP PHYS PHAR 1008:Layout 4.Qxd Physician and Pharmacist Reference Guide October 2008 Value Plus For the most up-to-date drug list visit www.caremark.com The Caremark Value Plus 3-Tier Formulary, formerly the PharmaCare Value Plus 3-Tier Formulary, is a guide within select therapeutic categories for clients, plan participants and health care providers. Generics should be considered the first line of prescribing. If there is no generic available, there may be more than one brand-name medicine to treat a condition. These preferred brand-name medicines are listed to help identify products that are clinically appropriate and cost-effective. Generics listed in therapeutic categories are for representational purposes only. This is not an all-inclusive list. This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. HEALTH CARE PROVIDER THERAPEUTIC CATEGORIES Your patient is covered under a prescription benefit plan administered by Antidiabetic Agents 2 Caremark. As a way to help manage health care costs, authorize generic Allergy, Cough & Cold 2 substitution whenever possible. If you believe a brand-name product is necessary, consider prescribing a brand name on this list. Anti-Infective Agents 2 Please note: Antineoplastic 2 ● Generics should be considered the first line of prescribing. Autonomic and Central Nervous System Agents 2 ● This drug list represents a summary of prescription coverage. It is not inclusive Cardiovascular Agents 3 and does not guarantee coverage. Contraceptives 3 ● The plan participant’s specific prescription benefit plan may have a different Corticosteroids 4 copay1 for specific products on the list. Dermatologicals 4 ● Unless specifically indicated, drug list products will include all dosage forms. Diagnostics 4 ● Log in to www.caremark.com to check coverage and copay information for a specific medicine. Gastrointestinal Agents 4 Gout Agents 4 Hematopoietic Growth Factors 4 PLAN PARTICIPANT Hormones 4 Your benefit plan provides you with a prescription benefit program administered Immunologic Agents 4 by Caremark. Ask your doctor to consider prescribing, when medically appropriate, Immunosuppressive Agents 4 a preferred medicine from this list. Take this list along when you or a covered family member sees a doctor. Ophthalmics 4 Please note: Osteoporosis Agents 5 ● Your specific prescription benefit plan design may not cover certain categories, Otics 5 regardless of their appearance in this document. Phosphate Binder Agents 5 ● For specific information regarding your prescription benefit coverage and copay1 Respiratory/Asthma 5 information, please visit our Web site at www.caremark.com or contact a Skeletal Muscle Relaxants 5 Caremark Customer Care representative. Thyroid and Antithyroid Agents 5 ● Caremark may contact your doctor after receiving your prescription to request consideration of a drug list product or generic equivalent. This may result in Urinary Agents 5 your doctor prescribing, when medically appropriate, a different brand-name Vaginal Preparations 5 product or generic equivalent in place of your original prescription. Vitamins 5 Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document. For specific information, visit our Web site at www.caremark.com or contact a Caremark Customer Care representative. Page 1 of 5 ANTIDIABETIC AGENTS ANTITUSSIVE SULFONAMIDES ANTINEOPLASTIC ANALGESICS, SALICYLATES sulfamethoxazole- INSULINS COMBINATIONS diflunisal trimethoprim DS Generally, self-administered codeine-chlorpheniramine- single source brand drugs salsalate RAPID-ACTING INSULINS TETRACYCLINES pseudoephedrine indicated for the treatment APIDRA ANTICONVULSANTS codeine-guaifenesin doxycycline hyclate of cancer are formulary. HUMALOG minocycline carbamazepine HUMULIN R codeine-guaifenesin- pseudoephedrine tetracycline AUTONOMIC AND clonazepam NOVOLIN R ORACEA CENTRAL NERVOUS ethosuximide NOVOLOG codeine-promethazine codeine-promethazine- OTHER ANTI-INFECTIVES SYSTEM AGENTS gabapentin INTERMEDIATE-ACTING phenylephrine chloroquine ALZHEIMER’S AGENTS lamotrigine ODT INSULINS dextromethorphan- clindamycin phenobarbital HUMALOG MIX ARICEPT brompheniramine- dapsone phenytoin HUMULIN MIX EXELON pseudoephedrine ethambutol primidone HUMULIN N NAMENDA dextromethorphan- isoniazid valproic acid NOVOLIN MIX RAZADYNE promethazine mefloquine zonisamide NOVOLIN N RAZADYNE ER hydrocodone-homatropine metronidazole CARBATROL NOVOLOG MIX nitrofurantoin macrocrystals ANALGESICS, NARCOTIC DEPAKOTE LONG-ACTING INSULINS NASAL CORTICOSTEROIDS pyrazinamide codeine-acetaminophen DEPAKOTE ER LANTUS flunisolide rifampin fentanyl transdermal DEPAKOTE SPRINKLE LEVEMIR fluticasone trimethoprim hydrocodone- DIASTAT NASACORT AQ DILANTIN INFATAB ORAL ALINIA acetaminophen NASONEX FURADANTIN hydromorphone GABITRIL acarbose RHINOCORT AQUA MALARONE morphine KEPPRA glimepiride VERAMYST TINDAMAX morphine ext-rel LAMICTAL tablet glipizide TOBI morphine supp LYRICA glipizide ext-rel NASAL ANTIHISTAMINES VANCOCIN oxycodone TEGRETOL XR glipizide-metformin ASTELIN ZYVOX oxycodone ext-rel TOPAMAX glyburide oxycodone soln TRILEPTAL glyburide-metformin ANTI-INFECTIVE AGENTS ANTIFUNGAL AGENTS oxycodone-acetaminophen metformin ANTIPARKINSON AGENTS ANTHELMINTICS fluconazole AVINZA metformin ext-rel mebendazole itraconazole KADIAN benztropine ACTOPLUS MET terbinafine tablet OPANA ER bromocriptine ACTOS ANTIBIOTICS carbidopa-levodopa ANTIVIRALS OXYCONTIN DUETACT CEPHALOSPORINS carbidopa-levodopa ext-rel JANUMET cefaclor acyclovir ANALGESICS, selegiline JANUVIA cefdinir ganciclovir NON-NARCOTIC trihexyphenidyl PRANDIN cephalexin ribavirin butalbital-acetaminophen- APOKYN BARACLUDE MACROLIDES caffeine AZILECT OTHER DIABETIC AGENTS EPIVIR HBV azithromycin butalbital-aspirin-caffeine COMTAN BYETTA HEPSERA clarithromycin tramadol MIRAPEX GLUCAGEN HYPOKIT INFERGEN clarithromycin ext-rel PARCOPA GLUCAGON EMERGENCY KIT INTRON A ANALGESICS, erythromycin REQUIP SYMLIN PEGASYS NONSTEROIDAL delayed-rel STALEVO PEGINTRON ANTI-INFLAMMATORY erythromycin ethylsuccinate ALLERGY, PEGINTRON REDIPEN diclofenac ANXIOLYTICS, SEDATIVES, erythromycin stearate COUGH & COLD REBETOL soln etodolac AND HYPNOTICS ANTIHISTAMINE/ PENICILLINS TAMIFLU ibuprofen alprazolam DECONGESTANTS amoxicillin TYZEKA indomethacin buspirone amoxicillin-clavulanate cyproheptadine VALCYTE indomethacin ext-rel diazepam dicloxacillin fexofenadine VALTREX meloxicam lorazepam penicillin VK nabumetone oxazepam hydroxyzine HCl Generally, self-administered ALLEGRA-D QUINOLONES naproxen temazepam ciprofloxacin ext-rel single source brand drugs indicated for the treatment naproxen sodium triazolam ciprofloxacin tablet of HIV are formulary. oxaprozin zolpidem AVELOX sulindac LUNESTA LEVAQUIN Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document. For specific information, visit our Web site at www.caremark.com or contact a Caremark Customer Care representative. Page 2 of 5 CEREBRAL STIMULANTS ANTIMANIC AGENTS PERIPHERALLY ACTING COMBINATION CONTRACEPTIVES lithium carbonate doxazosin amphetamine- ANTIHYPERTENSIVES EE = ethinyl estradiol lithium carbonate ext-rel terazosin dextroamphetamine amlodipine-benazepril ME = mestranol FLOMAX dexmethylphenidate ANTIPSYCHOTIC AGENTS atenolol-chlorthalidone MONOPHASIC dextroamphetamine chlorpromazine ANTIARRHYTHMICS bisoprolol- clozapine desogestrel-EE dextroamphetamine ext-rel amiodarone hydrochlorothiazide fluphenazine ethynodiol diacetate-EE methylphenidate digoxin fosinopril- haloperidol levonorgestrel-EE methylphenidate ext-rel disopyramide hydrochlorothiazide perphenazine norethindrone acetate-EE ADDERALL XR disopyramide ext-rel lisinopril- thioridazine norethindrone CONCERTA flecainide hydrochlorothiazide thiothixene acetate-EE-iron DAYTRANA mexiletine metoprolol- trifluoperazine norethindrone-EE FOCALIN XR propafenone hydrochlorothiazide ABILIFY norethindrone-ME METADATE CD sotalol quinapril- FAZACLO norgestimate-EE METHYLIN sotalol AF hydrochlorothiazide GEODON norgestrel-EE RITALIN LA RYTHMOL SR ATACAND HCT INVEGA Apri STRATTERA TIKOSYN AVALIDE VYVANSE RISPERDAL BENICAR HCT Aviane SEROQUEL ANTICOAGULANTS/ CADUET Cryselle MIGRAINE AGENTS ZYPREXA ANTITHROMBOTICS MICARDIS HCT Junel dihydroergotamine warfarin Lessina CARDIOVASCULAR TARKA ergotamine-caffeine tablet AGGRENOX TEKTURNA HCT Levora IMITREX AGENTS ARIXTRA Low-Ogestrel MAXALT ALDOSTERONE COUMADIN DIRECT RENIN INHIBITORS Microgestin MIGRANAL ANTAGONISTS FRAGMIN TEKTURNA Microgestin FE ZOMIG Mononessa spironolactone INNOHEP DIURETICS Necon 1/50 MULTIPLE SCLEROSIS LOVENOX ANGIOTENSIN II furosemide Nortrel AGENTS PLAVIX ANTAGONISTS hydrochlorothiazide Portia COPAXONE ATACAND 2 ANTILIPEMICS metolazone Previfem REBIF AVAPRO cholestyramine spironolactone- Quasense hydrochlorothiazide OBSESSIVE-COMPULSIVE BENICAR colestipol Sprintec torsemide DISORDER AGENTS MICARDIS fenofibrate Zovia pravastatin triamterene- fluvoxamine YASMIN ANGIOTENSIN simvastatin hydrochlorothiazide CONVERTING ENZYME YAZ PSYCHOTHERAPEUTIC ADVICOR INHIBITORS PULMONARY BIPHASIC AGENTS LIPITOR HYPERTENSION fosinopril LOVAZA desogestrel-EE ANTIDEPRESSANTS REVATIO lisinopril NIASPAN Kariva amitriptyline TRACLEER quinapril SIMCOR bupropion TRIPHASIC ramipril TRICOR VASODILATORS bupropion ext-rel desogestrel-EE trandolapril VYTORIN citalopram dipyridamole levonorgestrel-EE WELCHOL clomipramine ANTI-ADRENERGIC hydralazine norethindrone-EE ZETIA desipramine AGENTS
Load more

Recommended publications
  • Penetration of Synthetic Corticosteroids Into Human Aqueous Humour
    Eye (1990) 4, 526--530 Penetration of Synthetic Corticosteroids into Human Aqueous Humour C. N. 1. McGHEE,1.3 D. G. WATSON, 3 1. M. MIDGLEY, 3 M. 1. NOBLE, 2 G. N. DUTTON, z A. I. FERNl Glasgow Summary The penetration of prednisolone acetate (1%) and fluorometholone alcohol (0.1%) into human aqueous humour following topical application was determined using the very sensitive and specific technique of Gas Chromatography with Mass Spec­ trometry (GCMS). Prednisolone acetate afforded peak mean concentrations of 669.9 ng/ml within two hours and levels of 28.6 ng/ml in aqueous humour were detected almost 24 hours post application. The peak aqueous humour level of flu­ orometholone was S.lng/ml. The results are compared and contrasted with the absorption of dexamethasone alcohol (0.1%), betamethasone sodium phosphate (0.1 %) and prednisolone sodium phosphate (0.5%) into human aqueous humour. Topical corticosteroid preparations have been prednisolone acetate (1.0%) and fluorometh­ used widely in ophthalmology since the early alone alcohol (0.1 %) (preliminary results) 1960s and over the last 10 years the choice of into the aqueous humour of patients under­ preparations has become larger and more going elective cataract surgery. varied. Unfortunately, data on the intraocular penetration of these steroids in humans has SUbjects and Methods not paralleled the expansion in the number of Patients who were scheduled to undergo rou­ available preparations; indeed until recently, tine cataract surgery were recruited to the estimation of intraocular penetration has study and informed consent was obtained in been reliant upon extrapolation of data from all cases (n=88), Patients with corneal disease animal models (see Watson et ai., 1988, for or inflammatory ocular conditions which bibliography).
    [Show full text]
  • [email protected]
    SAFETY DATA SHEET Revision Date 13-Jul-2016 Version 1 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Product identifier Product Name Pred Forte Other means of identification Product Code FP61 Synonyms Prednisolone Acetate Recommended use of the chemical and restrictions on use Recommended Use Corticosteroid This safety data sheet is written to provide health, safety and environmental information for people handling this formulated product in the workplace. It is not intended to provide information relevant to medicinal use of the product. In this instance patients should consult prescribing information/package insert/product label or consult their pharmacist or physician. For health and safety information for individual ingredients used during manufacturing, refer to the appropriate safety data sheet for each ingredient. Details of the supplier of the safety data sheet Manufacturer ALLERGAN 400 Interpace Parkway, Morris Corporate Center III Parsippany, NJ 07054, USA +1-800-272-5525 E-mail address [email protected] Emergency telephone number Emergency Telephone Call CHEMTREC Day or Night Within USA or Canada: 1-800-424-9300 Outside USA and Canada: +1-703-741-5970 (collect calls accepted) 2. HAZARDS IDENTIFICATION Classification OSHA Regulatory Status This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200) Reproductive toxicity Category 2 Effects on or via lactation Yes Label elements Emergency Overview Danger Hazard statements H362 - May cause harm to breast-fed
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Prednisolone Also Binds to Transcortin • Other Synthetic GS Only Bind to Albumin
    PK/PD considerations for corticosteroids P L Toutain, National Veterinary School, Toulouse, France Wuhan October 2015 1 Anti-inflammatory drugs Corticosteroids NSAIDs 2 Glucocorticoids: main properties • Glucocorticosteroids (GCS) are broad and potent anti- inflammatory drugs. • They are extensively used to mitigate or suppress inflammation associated with a variety of conditions especially joint and respiratory system inflammation. • GCs are not curative: • GCs are only palliative symptomatic treatments and chronic use of GCs can be, in fine , detrimental • GCs possess many other pharmacological properties (not reviewed in this presentation) 3 The cortisol or hydrocortisone 4 Cortisol : An endogenous hormone and a surrogate endpoint of the duration of the GCS effects; it physiology should be understood to use properly GCS 5 Cortisol synthesis • All GCs used in therapeutics are synthetic derivatives of cortisol. • Cortisol (hydrocortisone) is synthesized in the adrenal cortex and it is the main corticosteroid hormone in most species. 6 Steroids synthesis by the adrenal gland Aldosterone Cortisol Androgens Epinephrine (adrenalin) 7 Cortisol ou Hydrocortisone structure – activity relationship Three structural properties are required for a GC activity (i.e. for cortisol to bind to GC receptor) 8 Cortisol (hydrocortisone) • Minimal information on cortisol physiology (secretion, distribution & elimination ) needs to be known to understand the clinical pharmacology of GCS 9 Plasma cortisol • Cortisol levels are very different in domestic species • Pattern of secretion – Circadian rhythm (h) – Pulsatilty (minute) 10 Plasma cortisol level Plasma concentration (ng/mL) 600 500 400 300 Series1 200 100 0 1 2 3 4 5 11 Plasma cortisol levels: circadian rhythm & pulsatility Toutain et al. Domestic.Anim.Endocrinol.
    [Show full text]
  • Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Crizotinib (PF-02341066) 1 4 55 Docetaxel 1 5 98 Anastrozole 1 6 25 Cladribine 1 7 23 Methotrexate 1 8 -187 Letrozole 1 9 65 Entecavir Hydrate 1 10 48 Roxadustat (FG-4592) 1 11 19 Imatinib Mesylate (STI571) 1 12 0 Sunitinib Malate 1 13 34 Vismodegib (GDC-0449) 1 14 64 Paclitaxel 1 15 89 Aprepitant 1 16 94 Decitabine 1 17 -79 Bendamustine HCl 1 18 19 Temozolomide 1 19 -111 Nepafenac 1 20 24 Nintedanib (BIBF 1120) 1 21 -43 Lapatinib (GW-572016) Ditosylate 1 22 88 Temsirolimus (CCI-779, NSC 683864) 1 23 96 Belinostat (PXD101) 1 24 46 Capecitabine 1 25 19 Bicalutamide 1 26 83 Dutasteride 1 27 68 Epirubicin HCl 1 28 -59 Tamoxifen 1 29 30 Rufinamide 1 30 96 Afatinib (BIBW2992) 1 31 -54 Lenalidomide (CC-5013) 1 32 19 Vorinostat (SAHA, MK0683) 1 33 38 Rucaparib (AG-014699,PF-01367338) phosphate1 34 14 Lenvatinib (E7080) 1 35 80 Fulvestrant 1 36 76 Melatonin 1 37 15 Etoposide 1 38 -69 Vincristine sulfate 1 39 61 Posaconazole 1 40 97 Bortezomib (PS-341) 1 41 71 Panobinostat (LBH589) 1 42 41 Entinostat (MS-275) 1 43 26 Cabozantinib (XL184, BMS-907351) 1 44 79 Valproic acid sodium salt (Sodium valproate) 1 45 7 Raltitrexed 1 46 39 Bisoprolol fumarate 1 47 -23 Raloxifene HCl 1 48 97 Agomelatine 1 49 35 Prasugrel 1 50 -24 Bosutinib (SKI-606) 1 51 85 Nilotinib (AMN-107) 1 52 99 Enzastaurin (LY317615) 1 53 -12 Everolimus (RAD001) 1 54 94 Regorafenib (BAY 73-4506) 1 55 24 Thalidomide 1 56 40 Tivozanib (AV-951) 1 57 86 Fludarabine
    [Show full text]
  • Pharmacokinetics of Ophthalmic Corticosteroids
    British Journal ofOphthalmology 1992; 76: 681-684 681 MINI REVIEW Br J Ophthalmol: first published as 10.1136/bjo.76.11.681 on 1 November 1992. Downloaded from Pharmacokinetics of ophthalmic corticosteroids Corticosteroids have been used by ophthalmologists with an identical vehicle, the aqueous humour concentrations of increasing frequency over the past 30 years, with the these steroids are almost identical.'9 None the less it is concomitant development of a diverse range of drop, essential when considering such empirical data, to recall that ointment, subconjunctival, and oral preparations. Though the systemic anti-inflammatory effect of both betamethasone the clinical benefits and side effects of such corticosteroid and dexamethasone is five to seven times that of predniso- preparations have been well documented, their basic lone.39"' The local anti-inflammatory potency of ocular pharmacokinetics in the human eye have yet to be fully steroids has yet to be fully investigated and whilst early work established. Indeed most of our pharmacokinetic knowledge suggested that prednisolone acetate 1% had the greatest anti- of these drugs has been elucidated by extrapolation of data inflammatory effect in experimental keratitis,'7 later studies obtained from rabbit experiments.1-26 These results can be demonstrated that fluorometholone acetate in a 1% formu- significantly disparate from human data because of the lation was equally efficacious in the same model.26 However, thinner rabbit cornea, lower rabbit blink rate, effect of prednisolone
    [Show full text]
  • Aetna Formulary Exclusions Drug List
    Covered and non-covered drugs Drugs not covered – and their covered alternatives 2020 Advanced Control Plan – Aetna Formulary Exclusions Drug List 05.03.525.1B (7/20) Below is a list of medications that will not be covered without a Key prior authorization for medical necessity. If you continue using one of these drugs without prior approval, you may be required UPPERCASE Brand-name medicine to pay the full cost. Ask your doctor to choose one of the generic lowercase italics Generic medicine or brand formulary options listed below. Preferred Options For Excluded Medications1 Excluded drug name(s) Preferred option(s) ABILIFY aripiprazole, clozapine, olanzapine, quetiapine, quetiapine ext-rel, risperidone, ziprasidone, VRAYLAR ABSORICA isotretinoin ACANYA adapalene, benzoyl peroxide, clindamycin gel (except NDC^ 68682046275), clindamycin solution, clindamycin-benzoyl peroxide, erythromycin solution, erythromycin-benzoyl peroxide, tretinoin, EPIDUO, ONEXTON, TAZORAC ACIPHEX, esomeprazole, lansoprazole, omeprazole, pantoprazole, DEXILANT ACIPHEX SPRINKLE ACTICLATE doxycycline hyclate capsule, doxycycline hyclate tablet (except doxycycline hyclate tablet 50 mg [NDC^ 72143021160 only], 75 mg, 150 mg), minocycline, tetracycline ACTOS pioglitazone ACUVAIL bromfenac, diclofenac, ketorolac, PROLENSA acyclovir cream acyclovir (except acyclovir cream), valacyclovir ADCIRCA sildenafil, tadalafil ADZENYS XR-ODT amphetamine-dextroamphetamine mixed salts ext-rel†, dexmethylphenidate ext-rel, dextroamphetamine ext-rel, methylphenidate ext-rel†, MYDAYIS,
    [Show full text]
  • Feline Eosinophilic Keratoconjunctivitis: Nonsteroidal Vs Corticosteroid Topical Treatment
    Acta Scientiae Veterinariae, 2021. 49(Suppl 1): 608. CASE REPORT ISSN 1679-9216 Pub. 608 Feline Eosinophilic Keratoconjunctivitis: Nonsteroidal vs Corticosteroid Topical Treatment Gabrielly da Costa Gomes Rodrigues1, Ana Maria Tatoni Pereira Coelho1, João Pedro Brochado Souza2, Joyce Maira de Araújo1, Márcio Virgílio Figueiredo da Silva1, Polyana Mayume Pereira da Silva3 & Gabriel Utida Eguchi1 ABSTRACT Background: Feline eosinophilic keratoconjunctivitis is a proliferative eye lesion of chronic aspect with usually unilateral presentation that may initiate as a superficial vascularization that evolves to a proliferative, granular, irregular lesion of whitish-pink aspect. With its association with an immune-mediated response, nonsteroidal anti-inflammatories do not appear to be efficient, although few studies describe its use. This case report describes a case of a feline eosinophilic kera- toconjunctivitis with its clinical evolution since the use of nonsteroidal topical anti-inflammatory drug in an undiagnosed patient and the transition to a topical corticosteroid and cure after 14 days since diagnosis. Case: An 8-year-old female cat was attended at the Veterinary Hospital of the Dom Bosco Catholic University (UCDB), with main complaint being an eye injury with at least 36 days of evolution and unresponsive to treatment (topical tobra- mycin 0.3% every 12 h / ketorolac trometamol 0.5%/ every 12 h and ophthalmic lubricant/every 4 h). Since the patient had free access to the street, the owners suspected of trauma-induced lesion. At physical examination, it was observed a proliferative lesion at the peri-limbal superotemporal quadrant of the right cornea with approximately 0.4 cm diameter, with color varying of pale to pink, with irregular surface and low vascularity, the adjacent conjunctiva was also affected with similar multiple nodular lesions (0.1 cm).
    [Show full text]
  • Medication Safety Communication – Prednefrin Forte Eye Drops 10Ml
    MEDICATION SAFETY COMMUNICATION Information for health professionals in NSW public health organisations Prednefrin Forte eye drops 10mL – 3 March 2021 Prednefrin Forte (prednisolone acetate 1%, phenylephrine 0.12% Details of affected product(s) suspension) 10mL eye drops – ARTG 23235 Reason for communication Supply disruption – manufacturing reasons Shortage commencement date 22 February 2021 Estimated resolution date 1 January 2022 Main therapeutic applications Severe noninfectious eye inflammation such as acute iritis, iridocyclitis, scleritis, episcleritis, uveitis, resistant ocular allergy and post-surgery e.g. post-operative care for cataract and other intraocular surgery. Alternative agents • Equivalent alternatives to the Australian registered prednisolone acetate 1% / phenylephrine 0.12% eye drops (Prednefrin Forte) are unavailable and at this time, there is no provisionally registered product available through Section 19A of the Therapeutic Goods Act. • Existing Prednefrin Forte stock should be reserved for use in patients where alternative agents may be inappropriate e.g. allergy or clinical indication. • In the absence of Prednefrin Forte: • Dexamethasone 0.1% eye drops (Maxidex) are the preferred alternative (as per ACI Ophthalmology Network). Consult with local Ophthalmology teams for situations where other agents may be preferred. • For indications where prednisolone acetate 1% / phenylephrine 0.12% eye drops are essential, sites may wish to consider local aseptic compounding options. • Medsurge Healthcare may be able to supply prednisolone acetate 1% (Pred Forte) eye drops via the Therapeutic Goods Administration’s Special Access Scheme (SAS). The product is registered in New Zealand, with product information and labelling in English. Lead time is 5-7 business days. • LINK Healthcare may also be able to provide prednisolone acetate 1% / phenylephrine hydrochloride 0.12% (Prednefrin Forte) eye drops via the SAS.
    [Show full text]
  • Preferred Drug List
    Kansas State Employee ANALGESICS Second Generation cefprozil Health Plan NSAIDs cefuroxime axetil diclofenac sodium delayed-rel Preferred Drug List diflunisal Third Generation etodolac cefdinir 2021 ibuprofen cefixime (SUPRAX) meloxicam nabumetone Erythromycins/Macrolides naproxen sodium tabs azithromycin naproxen tabs clarithromycin oxaprozin clarithromycin ext-rel sulindac erythromycin delayed-rel erythromycin ethylsuccinate NSAIDs, COMBINATIONS erythromycin stearate diclofenac sodium delayed-rel/misoprostol fidaxomicin (DIFICID) Effective 04/01/2021 NSAIDs, TOPICAL Fluoroquinolones diclofenac sodium gel 1% ciprofloxacin For questions or additional information, diclofenac sodium soln levofloxacin access the State of Kansas website at moxifloxacin http://www.kdheks.gov/hcf/sehp or call COX-2 INHIBITORS Penicillins the Kansas State Employees Prescription celecoxib amoxicillin Drug Program at 1-800-294-6324. amoxicillin/clavulanate The Preferred Drug List is subject to change. GOUT amoxicillin/clavulanate ext-rel To locate covered prescriptions online, allopurinol ampicillin access the State of Kansas website at colchicine tabs dicloxacillin http://www.kdheks.gov/hcf/sehp for the probenecid penicillin VK most current drug list. colchicine (MITIGARE) Tetracyclines What is a Preferred Drug List? OPIOID ANALGESICS doxycycline hyclate A Preferred Drug List is a list of safe and buprenorphine transdermal minocycline cost-effective drugs, chosen by a committee codeine/acetaminophen tetracycline of physicians and pharmacists. Drug lists fentanyl
    [Show full text]
  • Preferred Drug List
    October 2021 Preferred Drug List The Preferred Drug List, administered by CVS Caremark® on behalf of Siemens, is a guide within select therapeutic categories for clients, plan members and health care providers. Generics should be considered the first line of prescribing. If there is no generic available, there may be more than one brand-name medicine to treat a condition. These preferred brand-name medicines are listed to help identify products that are clinically appropriate and cost-effective. Generics listed in therapeutic categories are for representational purposes only. This is not an all-inclusive list. This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. PLAN MEMBER HEALTH CARE PROVIDER Your benefit plan provides you with a prescription benefit program Your patient is covered under a prescription benefit plan administered administered by CVS Caremark. Ask your doctor to consider by CVS Caremark. As a way to help manage health care costs, prescribing, when medically appropriate, a preferred medicine from authorize generic substitution whenever possible. If you believe a this list. Take this list along when you or a covered family member brand-name product is necessary, consider prescribing a brand name sees a doctor. on this list. Please note: Please note: • Your specific prescription benefit plan design may not cover • Generics should be considered the first line of prescribing. certain products or categories, regardless of their appearance in • This drug list represents a summary of prescription coverage. It is this document. Products recently approved by the U.S. Food and not all-inclusive and does not guarantee coverage.
    [Show full text]
  • Cancer Drugs -Oral Blood Thinners (Anticoagulants) (Antineoplastics)
    BLOOD CANCER DRUGS-OTHER (ANTINEOPLASTICS) BLOOD MODIFIERS CANCER DRUGS-OTHER (ANTINEOPLASTICS) anagrelide (P) NEUPOGEN SYLATRON (P) pentoxifylline (M) (P) PROCRIT CANCER DRUGS -ORAL BLOOD THINNERS (ANTICOAGULANTS) (ANTINEOPLASTICS) COUMADIN (M) CANCER DRUGS -ORAL (ANTINEOPLASTICS) enoxaparin (M) anastrozole fondaparinux (P) AFINITOR FRAGMIN (M) bicalutamide PRADAXA (P) (M) BOSULIF warfarin (P) CAPRELSA (M) STROKE PREVENTION exemestane ERIVEDGE (P) (M) GLEEVEC (P) clopidogrel (P) ticlopidine (M) HYCAMTIN INLYTA (P) (M) CANCER DRUGS-OTHER letrozole NEXAVAR (P) (ANTINEOPLASTICS) (P) REVLIMID (P) CANCER DRUGS-OTHER SPRYCEL (ANTINEOPLASTICS) JAKAFI (P) KEY: Preferred Brand-name Drugs (Tier 2) Generic Drugs (Tier 1) P = Prior Authorization Required, Q = Quantity Limit, M = Maintenance Medication CANCER DRUGS -ORAL CENTRAL NERVOUS SYSTEM (ANTINEOPLASTICS) ANTI-PARKINSON DRUGS CANCER DRUGS -ORAL (M) (ANTINEOPLASTICS) pramipexole ropinirole (M) STIVARGA (P) selegiline (M) SUTENT (P) TARCEVA (P) ATTENTION DEFICIT DISORDER (ADD), TASIGNA (P) NARCOLEPSY (P) TEMODAR (M) (P) amphetamine/dextroamphetamine THALOMID (M) (P) dexmethylphenidate TYKERB (M) (P) dextroamphetamine VOTRIENT (M) (P) methamphetamine XALKORI (M) (P) methylphenidate sr XELODA (M) XTANDI (P) methylphenidate ZELBORAF (P) (P) SEIZURE MEDICATIONS (ANTICONVULSANTS) ZOLINZA (P) ZYTIGA carbamazepine extended release (M) carbamazepine (M) CENTRAL NERVOUS SYSTEM clonazepam (M) diazepam (M) ALZHEIMER'S DRUGS divalproex (M) (M) (M) divalproex sodium ARICEPT-23 (M) (M) ethosuximide donepezil
    [Show full text]